| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/26/2011 | EP2276746A1 Substituted pyridazinylmethyl sulfonamides |
| 01/26/2011 | EP2276744A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof |
| 01/26/2011 | EP2276741A1 Isoquinolinone derivatives as nk3 antagonists |
| 01/26/2011 | EP2276732A1 Novel estrogen receptor ligands |
| 01/26/2011 | EP2276731A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10 |
| 01/26/2011 | EP2276730A2 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/26/2011 | EP1948616B1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 01/26/2011 | EP1919898B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/26/2011 | EP1831173B1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 01/26/2011 | EP1638936B1 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | EP1489080B1 Process for producing cilostazol |
| 01/26/2011 | CN1918128B Fused ring 4-oxopyrimidine derivative |
| 01/26/2011 | CN1726603B Charge transport compositions and electronic devices made with such compositions |
| 01/26/2011 | CN101959970A Azo pigment composition, process for production of the composition, dispersions containing the composition, colored compositions and jet printing ink |
| 01/26/2011 | CN101959969A Azo pigment composition, process for production of the composition, dispersions containing the composition, colored compositions and jet printing ink |
| 01/26/2011 | CN101959882A 咪唑羰基化合物 Imidazole-carbonyl compound |
| 01/26/2011 | CN101955494A Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 01/26/2011 | CN101955464A 4-(4-methoxybenzylamino)-3-(5-nitro-4-thiocyanic acid pyrimidine-2-amino) benzonitrile, preparation method and application thereof |
| 01/26/2011 | CN101058561B Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof |
| 01/25/2011 | US7875728 Hydrazonopyrazole derivatives and their use as therapeutics |
| 01/25/2011 | US7875725 Primary explosives |
| 01/25/2011 | US7875643 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 01/25/2011 | US7875621 Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors |
| 01/25/2011 | US7875619 Hetero substituted sodium channel blockers |
| 01/25/2011 | US7875615 Substituted triazole derivatives as oxytocin antagonists |
| 01/25/2011 | US7875605 1-Benzenesulfonyl-3-(4-methylpiperazin-1-ylmethyl)-5-nitro-1 H-indole; 1-[[5-Bromo-1-(2-Bromo-4-methoxybenzenesulfonyl)-indo1-3-yl]methyl][1,4]diazepane; useful for treating psychotic and neurodegenerative disorders e.g. schizophrenia, Alzheimer's disease, Parkinson's disease and Huntington's chorea |
| 01/25/2011 | CA2612287C Substituted arylpyrazoles for use against parasites |
| 01/25/2011 | CA2490141C 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 01/25/2011 | CA2388468C Mediators of hedgehog signalling pathways, compositions and uses related thereto |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/20/2011 | WO2011009084A2 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 01/20/2011 | WO2011008788A1 Fluoro-substituted compounds as kinase inhibitors and methods of use thereof |
| 01/20/2011 | WO2011008572A2 5-ht3 receptor modulators, methods of making, and use thereof |
| 01/20/2011 | WO2011008560A1 Emissive aryl-heteroaryl compounds |
| 01/20/2011 | WO2011008005A2 Method for preparing histidyl-prolinamide derivatives using a polymer solid phase support |
| 01/20/2011 | WO2011007819A1 Pharmaceutical product containing lactam or benzene sulfonamide compound |
| 01/20/2011 | WO2011006910A1 Imidazole derivatives as mglur5 antagonists |
| 01/20/2011 | WO2011006903A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | US20110015404 Electroluminescent Materials |
| 01/20/2011 | US20110015395 Pyrazole compounds with inhibitory activity against ros kinase |
| 01/20/2011 | US20110015394 Method of Synthesis of Bosentan, Its Polymorphic Forms and Its Salts |
| 01/20/2011 | US20110015234 Indazole derivatives |
| 01/20/2011 | US20110015218 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 01/20/2011 | US20110015207 Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity |
| 01/20/2011 | US20110015203 Viral Polymerase Inhibitors |
| 01/20/2011 | US20110015202 Imidazoles |
| 01/20/2011 | US20110015201 Hedgehog pathway antagonists and methods of use |
| 01/20/2011 | US20110015192 Sirtuin modulating compounds |
| 01/20/2011 | US20110015190 Gamma secretase modulators |
| 01/20/2011 | US20110015182 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
| 01/20/2011 | US20110015171 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015170 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015152 Diarylmethyl and related compounds |
| 01/20/2011 | US20110014291 Novel Polymorphs of Bosentan |
| 01/20/2011 | US20110014250 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages |
| 01/20/2011 | US20110012092 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same |
| 01/20/2011 | CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | CA2767887A1 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 01/20/2011 | CA2767233A1 5-ht3 receptor modulators, methods of making, and use thereof |
| 01/20/2011 | CA2765921A1 Imidazole derivatives as mglur5 antagonists |
| 01/19/2011 | EP2275422A1 Pyrimidinylpyrazoles as insecticide and parasiticide agents |
| 01/19/2011 | EP2275413A1 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders. |
| 01/19/2011 | EP2275412A1 Indole and benzimidazole derivatives |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2274303A1 Processes for preparing sunitinib and salts thereof |
| 01/19/2011 | EP2274298A1 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 01/19/2011 | EP2274297A1 Pyrrolidinone glucokinase activators |
| 01/19/2011 | EP2274294A1 5-demethoxyfumagillol and derivatives thereof |
| 01/19/2011 | EP2274288A2 Macrocyclic compounds and their use as kinase inhibitors |
| 01/19/2011 | EP2274287A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 01/19/2011 | EP2274282A1 Compounds for use in stabilizing p53 mutants |
| 01/19/2011 | EP2273992A1 Quenolines and related analogs as sirtuin modulators |
| 01/19/2011 | EP2150546B1 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
| 01/19/2011 | EP2035375B1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 01/19/2011 | EP1919899B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/19/2011 | EP1904482B1 Indolylmaleimide derivatives |
| 01/19/2011 | EP1644336B1 Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2011 | EP1330442B1 Phthalazinone derivatives |
| 01/19/2011 | EP1067123B1 Nitrogenous heterocyclic compounds |
| 01/19/2011 | CN1929847B Fasudil-containing preparation and method of improving stability thereof |
| 01/19/2011 | CN1816543B Indole derivatives with apoptosis-inducing effect |
| 01/19/2011 | CN101952292A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/19/2011 | CN101952278A 3-alkyl-piperazine derivatives and uses thereof |
| 01/19/2011 | CN101952275A Modulators for amyloid beta |
| 01/19/2011 | CN101952267A Cyclopropyl amine derivatives |
| 01/19/2011 | CN101952258A Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/19/2011 | CN101952247A Intermediate compounds for the preparation of meso-substituted cyanine, merocyanine and oxonole dyes |
| 01/19/2011 | CN101948709A Triazine derivate extreme-pressure antiwear agent containing ester group and preparation method thereof |
| 01/19/2011 | CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101250405B Novel mercapto fluorescence probe and uses thereof |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/19/2011 | CN101014578B Triazole derivative or salt thereof |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872123 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process making reaction products from cyclic α,β-unsaturated ketone substrates and nitroso substrates |
| 01/18/2011 | US7872039 3-aminoindazoles |
| 01/18/2011 | US7872035 Angiotensin II antagonists |